Preview Mode Links will not work in preview mode

The AI in Business Podcast is for non-technical business leaders who need to find AI opportunities, align AI capabilities with strategy, and deliver ROI.

Each week, Emerj Artificial Intelligence Research CEO Daniel Faggella interviews top AI executives from Fortune 500 firms and unicorn startups - to uncover trends, use-cases, and best practices for practical AI adoption.

Subscribe to Emerj's weekly AI newsletter by downloading our "Beginning with AI" PDF guide

Sep 30, 2018

We receive a lot of interest from business leaders in the domain of data enrichment, and we've executed on a few campaigns for these businesses. At the same time, our audience seems particularly interested in the collection of data to train a bespoke machine learning algorithm for business, asking questions related to...


Sep 27, 2018

There’s more to successful AI adoption than picking the right technology. Business leaders should be aware of the technical requirements of the initiative they’re undertaking, and few of those requirements are as important as data.

For this episode, we spoke with Mark Brayan, CEO of Appen, a firm that offers...


Sep 23, 2018

Over the last year, we've covered a lot of marketing applications. Many people know of our deep marketing research we've done on the landscape of machine learning in marketing applications and which industries will be affected first. But marketing doesn't tell the whole story when it comes to B2B sales. At some point,...


Sep 14, 2018

In this episode of the AI in Industry podcast, we interview Sumit Borar, Senior Director of Data Sciences and Engineering at Myntra, an eCommerce site for fashion, about the current and future state of eCommerce personalization and how the way customers in India purchase products online affect that personalization....


Sep 9, 2018

This week on AI in Industry, we speak with Amir Saffari, Senior Vice President of AI at BenevolentAI, a London-based pharmaceutical company that uses machine learning to find new uses for existing drugs and new treatments for diseases.

In speaking with him, we aim to learn two things:

  • How will machine learning play a...